Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice
Purpose: Squamous cell carcinoma of the oral cavity is one of the most common human neoplasms, and prevention of these carcinomas requires a better understanding of the carcinogenesis process and a model system in which cancer chemoprevention agents can be tested. We have developed a mouse model usi...
Saved in:
Published in | Clinical cancer research Vol. 10; no. 1; pp. 301 - 313 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Association for Cancer Research
01.01.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Purpose: Squamous cell carcinoma of the oral cavity is one of the most common human neoplasms, and prevention of these carcinomas
requires a better understanding of the carcinogenesis process and a model system in which cancer chemoprevention agents can
be tested. We have developed a mouse model using the carcinogen 4-nitroquinoline 1-oxide (4-NQO) in the drinking water to
induce tumorigenesis in the mouse oral cavity.
Experimental Design: 4-NQO was delivered by tongue painting or drinking water to two mouse strains, CBA and C57Bl/6. The incidences of oral cavity
carcinogenesis were then compared. In addition, we examined the expression of some of the molecular markers associated with
the process of human oral cavity and esophageal carcinogenesis, such as keratin (K) 1, K14, p16, and epidermal growth factor
receptor, by immunohistochemistry.
Results: After treatment with 4-NQO in the drinking water, massive tumors were observed on the tongues of both CBA and C57Bl/6 female
mice. Pathological analyses indicated that flat squamous dysplasias, exophytic papillary squamous tumors (papillomas), and
invasive squamous cell carcinomas were present. Immunohistochemistry analyses showed that 4-NQO changed the expression patterns
of the intermediate filament proteins K14 and K1. K14 was expressed in the epithelial suprabasal layers, in addition to the
basal layer, in tongues from carcinogen-treated animals. In contrast, control animals expressed K14 only in the basal layer.
Moreover, we observed more bromodeoxyuridine staining in the tongue epithelia of 4-NQO-treated mice. Reduced expression of
the cell cycle inhibitor, p16, was observed, whereas 4-NQO treatment caused an increase in epidermal growth factor receptor
expression in the mouse tongues. Interestingly, similar features of carcinogenesis, including multiple, large (up to 0.5 cm)
exophytic papillary squamous tumors and invasive squamous cell carcinomas, increased bromodeoxyuridine staining, and increased
K14 expression, were also observed in the esophagi of 4-NQO-treated mice. However, no tumors were observed in the remainder
of digestive tract (including the forestomach, intestine, and colon) or in the lungs or livers of 4-NQO-treated mice. These
results indicate that this murine 4-NQO-induced oral and esophageal carcinogenesis model simulates many aspects of human oral
cavity and esophageal carcinogenesis.
Conclusions: The availability of this mouse model should permit analysis of oral cavity and esophageal cancer development in various mutant
and transgenic mouse strains. This model will also allow testing of cancer chemopreventive drugs in various transgenic mouse
strains. |
---|---|
ISSN: | 1078-0432 1557-3265 |
DOI: | 10.1158/1078-0432.CCR-0999-3 |